The strange case of WazirX ownership without any stake for Binance
Akumentis Healthcare posts Rs 340 Cr revenue in FY22; remains profitable
From Rs 51 Cr in FY20 to Rs 1,272 Cr revenue in FY21: The story of Molbio Diagnostics
/entrackr/media/agency_attachments/2024/10/18/XDGqYgwk8PhvKwQWyFWY.png)
/entrackr/media/post_attachments/wp-content/uploads/2022/08/Razorpay-and-Ezetap.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2021/11/indifi.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2022/08/wazirx-binance-.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2022/08/Akumentis.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2022/05/Mobikwik.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2022/07/Biryani-by-kilo-and-Biryani-blues.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2022/06/jai-kisan.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2022/07/Ixigo.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2022/07/molbio.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2021/10/Fi.jpg)
